FDA publishes Action Plan to regulate AI and ML based products
FDA publishes Action Plan to regulate AI and ML based products The FDA has advanced an Action Plan focussed on possible means and methods of regulating AI/ML based products (AP)Premium The Action Plan furthers and builds on concepts covered in a discussion paper released in April 2019 Share Via Read Full Story On 12 January 2021, the US Food and Drug Administration (FDA) published a five part action plan which provides short-term actions to regulate products that incorporate artificial intelligence and/or machine learning (AI/ML). This 'Artificial Intelligence/Machine Learning (AI/ML)-Based ...
Source: livemint.com